Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Genetic Testing × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Polycystic Ovary Syndrome 1 Neoplastic Syndromes, Hereditary 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Melanoma 1 Lipodystrophy, Familial Partial 1 Histiocytosis, Non-Langerhans-Cell 1 Histiocytosis, Langerhans-Cell 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Glioma 1 Early Detection of Cancer 1 Colorectal Neoplasms 1 Castleman Disease 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Screening 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pertuzumab 4 Trastuzumab 4 Docetaxel 3 tucatinib 2 pyrotinib 1 Paclitaxel 1 Injections 1 Fluorodeoxyglucose F18 1 Carboplatin 1 Capecitabine 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡